# Provectus Biopharmaceuticals, Inc.: Form 8-K, filed Dec 11, 2024

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 09:00 ET
- Period: 2024-12-05
- Accession: 0001493152-24-049571
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315224049571/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315224049571/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315224049571/form8-k.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-049571. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.